Cruz JM - Search Results

1

Menogaril in the treatment of relapsed multiple myeloma. A phase II trial of the Cancer Center of Wake Forest University.

Cruz JM, Case LD, Dalton HB, Ramseur WL, Richards F 2nd, Jackson DV, Muss HB, Zekan PJ, Brodkin RA, Brown RC, et al. Cruz JM, et al. Invest New Drugs. 1992 Apr;10(1):35-7. doi: 10.1007/BF01275478. Invest New Drugs. 1992. PMID: 1535064 Clinical Trial.

2

High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association.

Muss HB, Case LD, Capizzi RL, Cooper MR, Cruz J, Jackson D, Richards F 2nd, Powell BL, Spurr CL, White D, et al. Muss HB, et al. J Clin Oncol. 1990 Nov;8(11):1797-805. doi: 10.1200/JCO.1990.8.11.1797. J Clin Oncol. 1990. PMID: 2230868 Clinical Trial.

3

A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphoma.

Muss HB, Spell N, Scudiery D, Capizzi RL, Cooper MR, Cruz J, Jackson DV, Richards F 2nd, Spurr CL, White DR, et al. Muss HB, et al. Invest New Drugs. 1990 Feb;8(1):125-30. doi: 10.1007/BF00216938. Invest New Drugs. 1990. PMID: 2345067

4

High-dose progestin therapy for metastatic breast cancer.

Muss HB, Cruz JM. Muss HB, et al. Among authors: cruz jm. Ann Oncol. 1992 Aug;3 Suppl 3:15-20. doi: 10.1093/annonc/3.suppl_3.s15. Ann Oncol. 1992. PMID: 1390312 Review.

5

High-dose megestrol acetate as third-line endocrine therapy for metastatic breast cancer.

Cruz JM, Muss HB, Russell G. Cruz JM, et al. Oncology. 1992;49 Suppl 2:8-11. doi: 10.1159/000227119. Oncology. 1992. PMID: 1461630 Clinical Trial.

6

Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association.

Muss HB, Case LD, Richards F 2nd, White DR, Cooper MR, Cruz JM, Powell BL, Spurr CL, Capizzi RL. Muss HB, et al. Among authors: cruz jm. N Engl J Med. 1991 Nov 7;325(19):1342-8. doi: 10.1056/NEJM199111073251904. N Engl J Med. 1991. PMID: 1922236 Free article. Clinical Trial.

7

Combination high-dose etoposide and vincristine infusion.

Jackson DV Jr, Cruz JM, White DR, Muss HB, Chauvenet AR. Jackson DV Jr, et al. Among authors: cruz jm. Invest New Drugs. 1990;8 Suppl 1:S59-64. doi: 10.1007/BF00171985. Invest New Drugs. 1990. PMID: 2380018

8

Phase I study of vincristine and escalating doses of etoposide.

Jackson DV Jr, Cruz JM, Zekan PJ, Caponera ME, Spurr CL, White DR, Richards F 2nd, Muss HB. Jackson DV Jr, et al. Among authors: cruz jm. Invest New Drugs. 1989 Jul;7(2-3):203-7. doi: 10.1007/BF00170858. Invest New Drugs. 1989. PMID: 2793373

9

Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study.

Muss HB, Case LD, Atkins JN, Bearden JD 3rd, Cooper MR, Cruz JM, Jackson DV Jr, O'Rourke MA, Pavy MD, Powell BL, et al. Muss HB, et al. Among authors: cruz jm. J Clin Oncol. 1994 Aug;12(8):1630-8. doi: 10.1200/JCO.1994.12.8.1630. J Clin Oncol. 1994. PMID: 8040675 Clinical Trial.

10

Chemoinfusion of the hepatic artery for metastases to the liver.

Sterchi JM, Richards F, White DR, Muss HB, Cooper MR, Jackson DV, Spurr CL, Capizzi RL, Cruz J, Zekan PJ. Sterchi JM, et al. Among authors: cruz j. Surg Gynecol Obstet. 1989 Apr;168(4):291-5. Surg Gynecol Obstet. 1989. PMID: 2522684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

266 results

Search Page

Filters